Literature DB >> 31745252

Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT).

P Tappenden1, Y Wang2, B Sharrack3, J Burman4, M Kazmi5, R Saccardi6, I Bermejo2, R Harvey7, M Badoglio8, D Farge9,10, J A Snowden11.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31745252     DOI： 10.1038/s41409-019-0747-2

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

Review 1.  Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Authors:  Tobias Alexander; Raffaella Greco
Journal:  Bone Marrow Transplant       Date:  2022-05-16       Impact factor: 5.174

2.  Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022.

Authors:  John A Snowden; Isabel Sánchez-Ortega; Selim Corbacioglu; Grzegorz W Basak; Christian Chabannon; Rafael de la Camara; Harry Dolstra; Rafael F Duarte; Bertram Glass; Raffaella Greco; Arjan C Lankester; Mohamad Mohty; Bénédicte Neven; Régis Peffault de Latour; Paolo Pedrazzoli; Zinaida Peric; Ibrahim Yakoub-Agha; Anna Sureda; Nicolaus Kröger
Journal:  Bone Marrow Transplant       Date:  2022-05-19       Impact factor: 5.174

3.  Selective cognitive dysfunction and physical disability improvement after autologous hematopoietic stem cell transplantation in highly active multiple sclerosis.

Authors:  N Giedraitiene; R Kizlaitiene; V Peceliunas; L Griskevicius; G Kaubrys
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

Review 4.  Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature.

Authors:  Francesco Patti; Clara Grazia Chisari; Simona Toscano; Sebastiano Arena; Chiara Finocchiaro; Vincenzo Cimino; Giuseppe Milone
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

5.  Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis Patients.

Authors:  Antonio Bertolotto; Serena Martire; Luca Mirabile; Marco Capobianco; Marco De Gobbi; Daniela Cilloni
Journal:  Neurol Ther       Date:  2020-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.